Atom Investors’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
Atom Investors's VCYT Position: Q2 2026 in Review
Atom Investors increased its Veracyte (VCYT) stake by 77% in Q2 2026, buying an estimated $220K and bringing the position to 12,104 shares worth $711K. The position accounts for 0.06% of the portfolio, ranked #457.
Atom Investors first reported a position in VCYT in Q4 2018 and has held it in 17 quarters since. The position peaked at $14.7M in Q1 2019. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- Atom Investors held 12,104 shares of Veracyte worth $711K as of Q2 2026.
- Atom Investors bought 5,254 Veracyte shares in Q2 2026, an estimated $220K.
- Veracyte made up 0.06% of Atom Investors's portfolio in Q2 2026, its #457 holding.
- Atom Investors first reported a position in Veracyte in Q4 2018 and has held it in 17 quarters since.
- Atom Investors's Veracyte position peaked at $14.7M in Q1 2019.
- 371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on Atom Investors's 13F filing for Q2 2026, filed 14 Aug 2026.